v3 Template
C

Curia Global Inc.

Pharmaceuticals / Biotechnology Albany, N.Y., USA ~150 employees
Founded
--
Employees (Est.)
~150
10 leaders known
Total Funding
$4.0M
Funding Rounds
1
Last Funding
2025-10-27

About Curia Global Inc.

Curia Global is a leading global Contract Development and Manufacturing Organization (CDMO) with over 30 years of experience in guiding clients through drug discovery, development, and manufacturing. They aim to be a dedicated ally, offering flexible and scalable solutions to accelerate the delivery of products to patients, supported by deep scientific expertise and a robust global network across North America, Europe, and India.

Products & Services

Small Molecule:Services include drug discovery, development, and manufacturing, covering assay development, medicinal chemistry, API manufacturing, high potency compounds, and fine chemicals like 4-FPBA and T3P reagent.
Generic APIs:Offers an API catalog and intellectual property services to support generic drug production.
Biologics:Comprehensive capabilities from discovery to GMP manufacturing, including antibody discovery, recombinant protein production, mRNA development, and mammalian drug substance manufacturing.
Sterile Drug Product:Expertise in clinical and commercial sterile manufacturing, including formulation development and process development for injectable drugs.
Analytical Testing Services:Includes batch release, stability testing, method development, validation, and solid-state chemistry analysis.

Specialties

Drug Discovery Drug Development Drug Manufacturing Small Molecule APIs Biologics Sterile Injectables Analytical Testing Generic APIs High Potency Compounds mRNA Development

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Internal Investment
T: -
FT: Internal Investment
A: 4000000
MR: -
FA: $4 million
FAN: 4000000
D: 2025-10-27
FD: 2025-10-27
-
Internal Investment Latest
2025-10-27
$4.0M

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

T

Thomas E. D'Ambra

Ph.D.

P

Philip Macnabb

Chief Executive Officer

G

Gerald Auer

Chief Financial Officer

M

Mariesa Coppola

Senior Vice President, General Counsel & Corporate Secretary

M

Meera Khullar

Senior Vice President, Quality & Compliance

G

Gregg Kuzma

Senior Vice President and Chief Information Officer

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

Curia Global Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Pharmaceuticals / Biotechnology
Company Size
~150 employees (est.)
Locations
Albany, N.Y., USA

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro